Evaluation of Ezetimibe and Atorvastatin Coadministration Versus Atorvastatin or Rosuvastatin Monotherapy in Japanese Patients With Hypercholesterolemia (Study P06027)(COMPLETED)
Ezetimibe Phase IV Clinical Study in Patients With Hypercholesterolemia
Sponsor: Organon and Co
A PHASE4 clinical study on Primary Hypercholesterolemia, this trial is completed. The trial is conducted by Organon and Co and has accumulated 9 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jun 2024 — Jul 2024 [monthly]
Completed PHASE4
-
Mar 2022 — Jun 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Mar 2022 [monthly]
Completed PHASE4
▶ Show 4 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
-
Jul 2017 — Jun 2018 [monthly]
Completed PHASE4
-
Feb 2017 — Jul 2017 [monthly]
Completed PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE4
First recorded
Feb 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Organon and Co
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.